ASB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.18699999513461E-09 |
Normal-vs-Stage2 |
8.11040012926867E-10 |
Normal-vs-Stage3 |
1.11022302462516E-16 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
2.459700E-02 |
Stage1-vs-Stage3 |
2.11349999945654E-07 |
Stage1-vs-Stage4 |
6.10779999999922E-05 |
Stage2-vs-Stage3 |
1.247350E-01 |
Stage2-vs-Stage4 |
3.733800E-01 |
Stage3-vs-Stage4 |
4.695600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
<1E-12 |
Normal-vs-AfricanAmerican |
2.03330000003721E-06 |
Normal-vs-Asian |
1.699760E-02 |
Caucasian-vs-AfricanAmerican |
3.345200E-01 |
Caucasian-vs-Asian |
4.896400E-01 |
AfricanAmerican-vs-Asian |
7.474800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.84618986764917E-12 |
Male-vs-Female |
2.413600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.32029999658323E-08 |
Normal-vs-Age(41-60Yrs) |
2.69650968220958E-12 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
6.78339995285882E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.911800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.306200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.006000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.422800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.376400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.387200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.021800E-03 |
Normal-vs-Grade 2 |
2.55909959889777E-10 |
Normal-vs-Grade 3 |
1.62458935193399E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
6.542400E-01 |
Grade 1-vs-Grade 3 |
1.383830E-01 |
Grade 1-vs-Grade 4 |
8.176500E-03 |
Grade 2-vs-Grade 3 |
1.004050E-02 |
Grade 2-vs-Grade 4 |
9.68599999999764E-05 |
Grade 3-vs-Grade 4 |
8.233700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.48854278797717E-12 |
Normal-vs-ccB subtype |
5.63149527010864E-11 |
ccA subtype-vs-ccB subtype |
1.950370E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.23154827949656E-13 |
Normal-vs-N1 |
1.164240E-03 |
N0-vs-N1 |
6.589800E-01 |
|
|